LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Texas Court Reverses Ortho Surgeon’s $9M Win
Legal & Regulatory and Reimbursement

Texas Court Reverses Ortho Surgeon’s $9M Win

July 22, 2021 1 min read Premium comments

Advertisement

Texas Court Reverses Ortho Surgeon’s $9M Win
The Old Harris County Courthouse, home of the First and Fourteenth Courts of Appeals of Texas / Source: Wikimedia and i_am_jim
Secondary#houstonmetroorthoandspinesurgery

The Texas Fourteenth District Court of Appeals (appellate court), via a three-judge panel, has reversed a $9 million judgment won by an orthopedic spine surgeon against a Texas ambulatory surgical center.

In 2012, Houston Metro Ortho and Spine Surgery, LLC (Metro), an ambulatory surgical center, opened. Richard Francis, M.D., via his business entity Juansrich, Ltd., owned an interest in Metro. According to court documents, Metro had initial success. Dr. Francis contributed to its success, providing more than 20% of its revenue.

In 2014, “two large insurance companies stopped paying Metro for services rendered to their insureds.” Consequently, Dr. Francis began performing procedures at other facilities. That same year, the Metro board of directors voted to remove Juansrich as a member.

In 2015, Metro sued Dr. Francis alleging that he had violated his noncompete agreement. Juansrich intervened. Juansrich alleged breach of contract, conversion, aiding and abetting, and unjust enrichment.

Dr. Francis filed a successful motion for summary judgment, arguing that the noncompete was unenforceable. The trial court then “realigned the parties making Juansrich the plaintiff” and later granted Juansrich’s two Rule 166 motions.

After a bench trial, the trial court awarded “Juansrich $9,855,596.85 in damages on Juansrich’s conversion cause of action and $23,048.50 in attorney’s fees.” The trial court also awarded “Dr. Francis $403,918.15 in attorney’s fees and costs for defending against Metro’s noncompete claim.”

Metro then appealed the trial court’s decision, challenging everything except its award of $23,048.50 in attorney’s fees. The appellate court reversed the trial court’s final judgment based on conversion. This means that Juansrich gets nothing for its conversion cause of action. The appellate court also reversed the trial court’s award of $403,918.15 in attorney’s fees and costs. It further found that the “trial court erred when it granted Juansrich’s first and second Rule 166 motions.”

All was not lost. The appellate court did conclude “that the evidence is legally sufficient to support the trial court’s judgment on Juansrich’s claim for missed distribution payments.” It affirmed “the final judgment’s award of $191,764.51 for missed distributions.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy